ConductScience.org, home

Paper2869486

Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.

Staerz UD and 1 other. Proc Natl Acad Sci U S A, 1986. Cited by 207 papers, by iCite.

Cite this record

ConductScience Library. Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. Papers, record 2869486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2869486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
207
iCite
Relative citation ratio, by iCite
4.18
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Staerz UDU D
2Bevan MJM J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antigens, SurfaceMajor topic
Receptors, Antigen, T-CellMajor topic
T-Lymphocytes, CytotoxicMajor topic
Animals
Antibody Specificity
Cytotoxicity, Immunologic
Hybridization, Genetic
Immunity, Cellular
Immunoglobulin Fab Fragments
Mice
Thy-1 Antigens

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI19335NIAID NIH HHSUnited StatesR01AI019335PubMed and NIHNIH RePORTER
CA25803NCI NIH HHSUnited StatesP01CA025803PubMed and NIHNIH RePORTER
R37AI019335NIHNIH RePORTER

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14972125Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy.J Exp Med1968https://conductscience.org/library/papers/4972125PubMed
213729244Recombination of a mixture of univalent antibody fragments of different specificity.Arch Biochem Biophys1961https://conductscience.org/library/papers/13729244PubMed
31172191Continuous cultures of fused cells secreting antibody of predefined specificity.Nature1975https://conductscience.org/library/papers/1172191PubMed
4818397Specific interaction between VH and VL regions of human monoclonal immunoglobulins.J Mol Biol1976https://conductscience.org/library/papers/818397PubMed
5821618Somatic cell hybridization of mouse myeloma cells.Cell1976https://conductscience.org/library/papers/821618PubMed
630693Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.Immunochemistry1978https://conductscience.org/library/papers/30693PubMed
76965328Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen.Science1980https://conductscience.org/library/papers/6965328PubMed
87391580Specific in vivo localization of monoclonal antibodies directed against the Thy 1.1 antigen.J Immunol1980https://conductscience.org/library/papers/7391580PubMed
96181166Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody.J Immunol1982https://conductscience.org/library/papers/6181166PubMed
106185617Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.J Exp Med1983https://conductscience.org/library/papers/6185617PubMed
116601175The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody.J Exp Med1983https://conductscience.org/library/papers/6601175PubMed
126604124Idiotype-like molecules on cells of a human T cell leukemia.J Exp Med1983https://conductscience.org/library/papers/6604124PubMed
136604129Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.J Exp Med1983https://conductscience.org/library/papers/6604129PubMed
146413583Biosynthesis, glycosylation, and in vitro translation of the human T cell antigen Leu-4.J Immunol1983https://conductscience.org/library/papers/6413583PubMed
156137772Hybrid hybridomas and their use in immunohistochemistry.Nature1983https://conductscience.org/library/papers/6137772PubMed
166227478Biosynthesis and molecular nature of the T3 antigen of human T lymphocytes.EMBO J1983https://conductscience.org/library/papers/6227478PubMed
176358356On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice.J Immunol1983https://conductscience.org/library/papers/6358356PubMed
186328306Somatic recombination in a murine T-cell receptor gene.Nature1984https://conductscience.org/library/papers/6328306PubMed
196206178The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype.J Exp Med1984https://conductscience.org/library/papers/6206178PubMed
206090932The structure, rearrangement and expression of D beta gene segments of the murine T-cell antigen receptor.Nature1984https://conductscience.org/library/papers/6090932PubMed

See all 34 referencesDownload CSV of references

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 207 citations.

PMIDTitleJournalYearIn PapersSource
42729476An Overview on T-Cell Engagers: The Current Position in Both the Biological and Mathematical Context.Comput Struct Biotechnol J2026https://conductscience.org/library/papers/42729476PubMed
42380631T cell engagers in autoimmune diseases.Nat Rev Immunol2026https://conductscience.org/library/papers/42380631PubMed
41262250Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives.Front Immunol2025https://conductscience.org/library/papers/41262250PubMed
41096731Special Issue: Antibody Therapy for Hematologic Malignancies.Int J Mol Sci2025https://conductscience.org/library/papers/41096731PubMed
39172329Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors.Mol Diagn Ther2024https://conductscience.org/library/papers/39172329PubMed
39054343CD28 co-stimulation: novel insights and applications in cancer immunotherapy.Nat Rev Immunol2024https://conductscience.org/library/papers/39054343PubMed
36877356Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.Arch Pharm Res2023https://conductscience.org/library/papers/36877356PubMed
36685546The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers.Front Immunol2022https://conductscience.org/library/papers/36685546PubMed
34874513Emerging immunological strategies: recent advances and future directions.Front Med2021https://conductscience.org/library/papers/34874513PubMed
32786324Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia.ACS Comb Sci2020https://conductscience.org/library/papers/32786324PubMed
32659909Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma.J Clin Med2020https://conductscience.org/library/papers/32659909PubMed
32296187Multispecific drugs herald a new era of biopharmaceutical innovation.Nature2020https://conductscience.org/library/papers/32296187PubMed
32111076Bispecific Antibodies and Antibody-Drug Conjugates for Cancer Therapy: Technological Considerations.Biomolecules2020https://conductscience.org/library/papers/32111076PubMed
31544847Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.Antibodies (Basel)2019https://conductscience.org/library/papers/31544847PubMed
30280288Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia.Curr Hematol Malig Rep2018https://conductscience.org/library/papers/30280288PubMed
30197788New developments in immunotherapy for lymphoma.Cancer Biol Med2018https://conductscience.org/library/papers/30197788PubMed
30132211Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies.BioDrugs2018https://conductscience.org/library/papers/30132211PubMed
29118005Redirecting T cells to hematological malignancies with bispecific antibodies.Blood2018https://conductscience.org/library/papers/29118005PubMed
29018834In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy.Mol Ther Methods Clin Dev2017https://conductscience.org/library/papers/29018834PubMed
27916996A New Agent in the Strategy to Cure AIDS.Mol Ther2016https://conductscience.org/library/papers/27916996PubMed

See all 51 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2869486

GET https://conductscience.org/api/papers/v1/2869486/references?page=2